InsiderTrades.com logo
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
I put all the details together for you here — but please hurry. 

NTLA Insider Trading

Insider Ownership Percentage: 3.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,085,489.31

Intellia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Intellia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intellia Therapeutics Share Price & Price History

Current Price: $12.18
Price Change: ▲ Price Increase of +0.1 (0.83%)
As of 12/20/2024 06:45 PM ET

This chart shows the closing price history over time for NTLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

Intellia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.1247,012View SEC Filing Icon  
7/1/2024Eliana ClarkEVPSell405$22.93$9,286.6571,470View SEC Filing Icon  
3/4/2024James BastaEVPSell2,297$32.99$75,778.0381,571View SEC Filing Icon  
1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.2543,927View SEC Filing Icon  
1/3/2024David LebwohlEVPSell5,843$29.46$172,134.7854,372View SEC Filing Icon  
1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.9040,585View SEC Filing Icon  
1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58846,486View SEC Filing Icon  
10/31/2023Muna BhanjiDirectorSell265$23.90$6,333.5011,996View SEC Filing Icon  
7/31/2023Muna BhanjiDirectorSell265$42.33$11,217.4512,261View SEC Filing Icon  
7/6/2023Muna BhanjiDirectorSell1,867$39.30$73,373.1012,526View SEC Filing Icon  
7/3/2023Eliana ClarkEVPSell360$40.51$14,583.6045,146View SEC Filing Icon  
6/20/2023Eliana ClarkEVPSell5,000$45.00$225,000.0045,146View SEC Filing Icon  
1/4/2023Glenn GoddardCFOSell2,427$37.21$90,308.6715,404View SEC Filing Icon  
1/4/2023John M LeonardCEOSell6,673$37.21$248,302.33766,825View SEC Filing Icon  
1/4/2023Laura Sepp-LorenzinoEVPSell2,508$37.21$93,322.6819,959View SEC Filing Icon  
1/1/2022Glenn GoddardCFOSell1,013$112.24$113,699.12View SEC Filing Icon  
1/1/2022John M LeonardCEOSell2,493$112.25$279,839.25View SEC Filing Icon  
1/1/2022Laura Sepp-LorenzinoEVPSell1,148$112.25$128,863.00View SEC Filing Icon  
See Full Table
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
I put all the details together for you here — but please hurry. 

SEC Filings (Institutional Ownership Changes) for Intellia Therapeutics (NASDAQ:NTLA)

88.77% of Intellia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NTLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Intellia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024Franklin Resources Inc.16,405$0.32M0.0%+10.3%0.016%Search for SEC Filing on Google Icon
11/25/2024Sanctuary Advisors LLC53,590$1.10M0.0%+147.9%0.053%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC20,304$0.42M0.0%N/A0.020%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC2,343,310$48.16M0.0%+2.2%2.301%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC292,795$6.02M0.0%+17.7%0.287%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd14,902$0.31M0.0%-70.5%0.015%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP644,763$13.25M0.0%-17.5%0.633%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP1,027,617$21.12M0.0%+33.5%1.009%Search for SEC Filing on Google Icon
11/15/2024Sphera Funds Management LTD.291,080$5.98M1.0%+108.8%0.286%Search for SEC Filing on Google Icon
11/15/2024State Street Corp5,143,534$105.70M0.0%+17.9%5.050%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp94,610$1.94M0.0%+3.4%0.093%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd7,345$0.15M0.0%N/A0.007%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.22,700$0.47M0.0%-49.8%0.022%Search for SEC Filing on Google Icon
11/15/2024Parallax Volatility Advisers L.P.35,994$0.74M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/15/2024Patient Square Capital LP128,569$2.64M1.0%N/A0.126%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC47,957$0.99M0.0%+28.3%0.047%Search for SEC Filing on Google Icon
11/15/2024HighTower Advisors LLC20,278$0.42M0.0%-12.8%0.020%Search for SEC Filing on Google Icon
11/15/2024Chevy Chase Trust Holdings LLC811,033$16.67M0.1%-22.2%0.796%Search for SEC Filing on Google Icon
11/15/2024Benjamin Edwards Inc.57,669$1.19M0.0%+13,762.7%0.057%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH22,100$0.46M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC14,814$0.30M0.0%-93.5%0.015%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC94,426$1.94M0.0%+116.3%0.093%Search for SEC Filing on Google Icon
11/14/2024Capstone Investment Advisors LLC61,129$1.26M0.0%+1.4%0.060%Search for SEC Filing on Google Icon
11/14/2024Rockefeller Capital Management L.P.76,038$1.56M0.0%-24.7%0.075%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC460,012$9.45M0.0%-10.2%0.452%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank26,905$0.55M0.0%-2.5%0.026%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets246,362$5.06M0.0%+88.0%0.242%Search for SEC Filing on Google Icon
11/13/2024FMR LLC2,339,522$48.08M0.0%+5.0%2.297%Search for SEC Filing on Google Icon
11/13/2024D.A. Davidson & CO.16,250$0.33M0.0%+34.3%0.016%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company53,545$1.10M0.0%-1.2%0.053%Search for SEC Filing on Google Icon
11/13/2024Horizon Kinetics Asset Management LLC13,792$0.28M0.0%-4.2%0.014%Search for SEC Filing on Google Icon
11/12/2024Algert Global LLC61,042$1.25M0.0%-10.7%0.060%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP13,020$0.27M0.1%N/A0.013%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.827,545$17.01M0.0%+4.8%0.815%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC28,203$0.58M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/8/2024Grandfield & Dodd LLC13,010$0.27M0.0%N/A0.013%Search for SEC Filing on Google Icon
11/8/2024Jennison Associates LLC47,899$0.98M0.0%+21.6%0.047%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP71,100$1.46M0.0%+35.3%0.070%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC19,748$0.41M0.0%+181.6%0.019%Search for SEC Filing on Google Icon
11/6/2024Curi RMB Capital LLC39,187$0.81M0.0%+13.5%0.039%Search for SEC Filing on Google Icon
11/6/2024KBC Group NV3,753$77K0.0%+37.3%0.004%Search for SEC Filing on Google Icon
11/5/2024Sumitomo Mitsui Trust Group Inc.3,149,399$64.72M0.0%-3.3%3.100%Search for SEC Filing on Google Icon
11/4/2024State of New Jersey Common Pension Fund D84,121$1.73M0.0%-2.0%0.083%Search for SEC Filing on Google Icon
11/4/2024Axxcess Wealth Management LLC20,215$0.42M0.0%+5.4%0.020%Search for SEC Filing on Google Icon
11/2/2024Privium Fund Management B.V.12,300$0.25M0.1%N/A0.012%Search for SEC Filing on Google Icon
11/1/2024Atria Investments Inc23,099$0.48M0.0%+24.3%0.023%Search for SEC Filing on Google Icon
11/1/2024Lewis Asset Management LLC66,308$1.36M1.0%+42.5%0.065%Search for SEC Filing on Google Icon
10/31/2024ARK Investment Management LLC12,255,440$251.85M2.3%+5.7%12.065%Search for SEC Filing on Google Icon
10/29/2024Harbor Capital Advisors Inc.79,205$1.63M0.1%+71.0%0.078%Search for SEC Filing on Google Icon
10/29/2024Capital Advisors Inc. OK203,775$4.19M0.1%-34.5%0.201%Search for SEC Filing on Google Icon
10/25/2024SteelPeak Wealth LLC19,106$0.39M0.0%N/A0.019%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.19,537$0.40M0.0%+72.4%0.019%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.3,674$77K0.0%+27.6%0.004%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.2,617$54K0.0%N/A0.003%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.53,721$1.10M0.1%+34.7%0.056%Search for SEC Filing on Google Icon
10/22/2024Eastern Bank2,000$41K0.0%N/A0.002%Search for SEC Filing on Google Icon
10/18/2024Raymond James & Associates178,254$3.66M0.0%-14.0%0.185%Search for SEC Filing on Google Icon
10/18/2024Blue Trust Inc.4,189$94K0.0%+182.7%0.004%Search for SEC Filing on Google Icon
10/16/2024nVerses Capital LLC6,900$0.14M0.1%N/A0.007%Search for SEC Filing on Google Icon
10/16/2024IQ EQ FUND MANAGEMENT IRELAND Ltd23,031$0.47M0.0%+75.2%0.024%Search for SEC Filing on Google Icon
10/11/2024Elmwood Wealth Management Inc.67,774$1.39M0.6%+0.9%0.067%Search for SEC Filing on Google Icon
10/11/2024Woodstock Corp25,550$0.53M0.1%+102.6%0.025%Search for SEC Filing on Google Icon
10/10/2024McGuire Investment Group LLC71,301$1.47M0.2%-1.0%0.074%Search for SEC Filing on Google Icon
10/5/2024Handelsbanken Fonder AB32,400$0.67M0.0%+24.1%0.034%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC24,144$0.50M0.0%+289.6%0.025%Search for SEC Filing on Google Icon
9/20/2024Healthcare of Ontario Pension Plan Trust Fund138,468$3.10M0.0%-41.8%0.144%Search for SEC Filing on Google Icon
9/5/2024Sanctuary Advisors LLC21,614$0.45M0.0%N/A0.022%Search for SEC Filing on Google Icon
8/16/2024Capital Impact Advisors LLC26,554$0.59M1.7%-17.0%0.028%Search for SEC Filing on Google Icon
8/16/2024Creative Planning12,334$0.28M0.0%-29.2%0.013%Search for SEC Filing on Google Icon
8/16/2024Algert Global LLC68,372$1.53M0.1%+307.0%0.071%Search for SEC Filing on Google Icon
8/15/2024Scientech Research LLC47,101$1.05M0.2%+133.0%0.049%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company54,192$1.21M0.0%-18.1%0.056%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC13,280$0.30M0.0%-94.6%0.014%Search for SEC Filing on Google Icon
8/14/2024EverSource Wealth Advisors LLC1,753$39K0.0%+763.5%0.002%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC17,963$0.40M0.0%-22.7%0.019%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC38,947$0.87M0.0%-19.4%0.040%Search for SEC Filing on Google Icon
8/13/2024Evolutionary Tree Capital Management LLC36,262$0.81M0.8%-1.4%0.038%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc36,019$0.81M0.0%+23.5%0.037%Search for SEC Filing on Google Icon
8/13/2024Thrivent Financial for Lutherans30,333$0.68M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/13/2024Sei Investments Co.9,282$0.21M0.0%+24.7%0.010%Search for SEC Filing on Google Icon
8/13/2024Orchard Capital Management LLC170,006$3.81M1.1%-1.3%0.176%Search for SEC Filing on Google Icon
8/13/2024Benjamin F. Edwards & Company Inc.60,913$1.36M0.0%+6,974.7%0.063%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd50,464$1.13M0.1%+176.3%0.052%Search for SEC Filing on Google Icon
8/12/2024Seven Eight Capital LP56,413$1.26M0.1%N/A0.058%Search for SEC Filing on Google Icon
8/12/2024Hsbc Holdings PLC36,631$0.81M0.0%+6.0%0.038%Search for SEC Filing on Google Icon
8/12/2024E Fund Management Co. Ltd.12,665$0.28M0.0%-12.4%0.013%Search for SEC Filing on Google Icon
8/10/2024Axxcess Wealth Management LLC19,171$0.43M0.0%+15.5%0.020%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC38,700$0.87M0.0%N/A0.040%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP1,324,561$29.65M0.0%+8.1%1.373%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.2,300,889$51.49M0.1%+19.2%2.385%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.330,514$7.40M0.0%+23.8%0.343%Search for SEC Filing on Google Icon
8/8/2024State of New Jersey Common Pension Fund D85,826$1.92M0.0%-14.9%0.089%Search for SEC Filing on Google Icon
8/7/2024Headlands Technologies LLC3,148$70K0.0%-61.3%0.003%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC7,014$0.16M0.0%-28.5%0.007%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC10,467$0.23M0.0%-40.0%0.011%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System25,648$0.57M0.0%+9.7%0.027%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers175,335$3.92M0.0%+5.3%0.182%Search for SEC Filing on Google Icon
8/1/2024Interchange Capital Partners LLC20,145$0.46M0.2%+84.7%0.021%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC27,537$0.62M0.0%-20.4%0.029%Search for SEC Filing on Google Icon
7/30/2024Pinnacle Associates Ltd.251,078$5.62M0.1%-1.8%0.260%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Intellia Therapeutics logo
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Read More on Intellia Therapeutics

Today's Range

Now: $12.18
Low: $11.85
High: $12.45

50 Day Range

MA: $15.59
Low: $12.02
High: $21.08

52 Week Range

Now: $12.18
Low: $11.79
High: $34.87

Volume

3,676,135 shs

Average Volume

1,784,817 shs

Market Capitalization

$1.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76

Who are the company insiders with the largest holdings of Intellia Therapeutics?

Intellia Therapeutics' top insider investors include:
  1. John M Leonard (CEO)
  2. James Basta (EVP)
  3. Eliana Clark (EVP)
  4. David Lebwohl (EVP)
  5. Michael P Dube (CAO)
  6. Laura Sepp-Lorenzino (EVP)
  7. Glenn Goddard (CFO)
  8. Muna Bhanji (Director)
Learn More about top insider investors at Intellia Therapeutics.

Who are the major institutional investors of Intellia Therapeutics?

Intellia Therapeutics' top institutional shareholders include:
  1. ARK Investment Management LLC — 12.06%
  2. State Street Corp — 5.05%
  3. Sumitomo Mitsui Trust Group Inc. — 3.10%
  4. Geode Capital Management LLC — 2.30%
  5. FMR LLC — 2.30%
  6. Two Sigma Advisers LP — 1.01%
Learn More about top institutional investors of Intellia Therapeutics stock.

Which institutional investors are selling Intellia Therapeutics stock?

Within the previous quarter, NTLA stock was sold by these institutional investors:
  1. Chevy Chase Trust Holdings LLC
  2. Jane Street Group LLC
  3. PDT Partners LLC
  4. Wellington Management Group LLP
  5. Sumitomo Mitsui Trust Group Inc.
  6. Capital Advisors Inc. OK
  7. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. Walleye Trading LLC
In the previous year, company insiders that have sold Intellia Therapeutics company stock include:
  1. John M Leonard (CEO)
  2. James Basta (EVP)
  3. Eliana Clark (EVP)
  4. David Lebwohl (EVP)
  5. Michael P Dube (CAO)
  6. Laura Sepp-Lorenzino (EVP)
  7. Glenn Goddard (CFO)
Learn More investors selling Intellia Therapeutics stock.

Which institutional investors are buying Intellia Therapeutics stock?

Within the last quarter, NTLA stock was purchased by institutional investors including:
  1. State Street Corp
  2. ARK Investment Management LLC
  3. Two Sigma Advisers LP
  4. Sphera Funds Management LTD.
  5. Patient Square Capital LP
  6. BNP Paribas Financial Markets
  7. FMR LLC
  8. Benjamin Edwards Inc.
Most People Are Dead Wrong.
From Brownstone Research   |   Ad
Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.
I call it my AI Retirement Playbook. I recommend you check it out now.